We are live on ! Find out more
TARA icon

Protara Therapeutics
TARA

44 hedge funds and large institutions have $126M invested in Protara Therapeutics in 2015 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 12 increasing their positions, 9 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 9

25% more funds holding in top 10

Funds holding in top 10: 4 → 5 (+1)

8% less funds holding

Funds holding: 48 → 44 (-4)

22% less capital invested

Capital invested by funds: $161M → $126M (-$34.7M)

67% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 6

Holders
44
Holders Change
-4
Holders Change %
-8.33%
% of All Funds
1.23%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.14%
New
2
Increased
12
Reduced
9
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
+$1.51M
2
MIM
Monashee Investment Management
Massachusetts
+$1.19M
3
Northern Trust
Northern Trust
Illinois
+$947K
4
BIT
BlackRock Institutional Trust
California
+$120K
5
State Street
State Street
Massachusetts
+$113K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$448K
2
TC
TFS Capital
Pennsylvania
-$377K
3
SIM
Spark Investment Management
New York
-$269K
4
Morgan Stanley
Morgan Stanley
New York
-$60.1K
5
RFC
Russell Frank Company
Washington
-$48K
Name Holding Trade Value Shares
Change 		Change in
Stake
PPCM
26
Pillar Pacific Capital Management
California
$159K – – –
TA
27
Teachers Advisors
New York
$157K – – –
Charles Schwab
28
Charles Schwab
California
$153K – – –
New York State Common Retirement Fund
29
New York State Common Retirement Fund
New York
$99K +$82.4K +133 +296%
BA
30
BlackRock Advisors
Delaware
$71K +$8.05K +13 +11%
NFA
31
Nationwide Fund Advisors
Ohio
$67K – – –
AIG
32
American International Group
New York
$63K – – –
Morgan Stanley
33
Morgan Stanley
New York
$43K -$60.1K -97 -56%
SO
34
STRS Ohio
Ohio
$34K – – –
Deutsche Bank
35
Deutsche Bank
Germany
$29K +$4.33K +7 +15%
BNP Paribas Financial Markets
36
BNP Paribas Financial Markets
France
$21.3K +$13.6K +22 +138%
ARMC
37
American Research & Management Company
Massachusetts
$14K – – –
Royal Bank of Canada
38
Royal Bank of Canada
Ontario, Canada
$11K +$4.33K +7 +58%
UBS Group
39
UBS Group
Switzerland
$4K -$4.33K -7 -50%
Wells Fargo
40
Wells Fargo
California
$1K -$5.57K -9 -90%
Barclays
41
Barclays
United Kingdom
$1K -$1.86K -3 -75%
HR
42
Howe & Rusling
New York
$1K – – –
Manulife (Manufacturers Life Insurance)
43
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$22 +$24.2K +39 New
TC
44
TFS Capital
Pennsylvania
– -$377K -528 Closed
SIM
45
Spark Investment Management
New York
– -$269K -378 Closed
RFC
46
Russell Frank Company
Washington
– -$48K -68 Closed
TRCT
47
Tower Research Capital (TRC)
New York
– -$15K -21 Closed
Invesco
48
Invesco
Georgia
– -$6K -9 Closed
Bank of America
49
Bank of America
North Carolina
– -$2.48K -4 -80%
Citigroup
50
Citigroup
New York
– -$1.86K -3 Closed
1
2

TARA Hedge Fund Activity: Q3 2015 in Review

44 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Protara Therapeutics (TARA) for Q3 2015, worth a combined $126M — down 22% from $161M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of TARA and 2 opened new positions — a net loss of 4 holders — while 9 trimmed existing stakes and 12 added.

The largest buyer was Baker Bros. Advisors, adding an estimated $1.51M. The largest seller was Vanguard Group, cutting an estimated $448K.

  • 44 institutional investors held Protara Therapeutics (TARA) as of Q3 2015, down from 48 in Q2 2015.
  • Funds reported $126M of Protara Therapeutics stock for Q3 2015, down 22% quarter-over-quarter.
  • 2 funds opened new Protara Therapeutics positions in Q3 2015 and 6 closed out, a net change of -4 holders.
  • The largest Protara Therapeutics buyer in Q3 2015 was Baker Bros. Advisors, an estimated $1.51M added.
  • The largest Protara Therapeutics seller in Q3 2015 was Vanguard Group, an estimated $448K sold.

Based on aggregated 13F filings for Q3 2015.